MT-ND1 Gene Mitochondrial Complex I Deficiency Genetic Test
Cost: 4400.0 AED
Symptoms, Diagnosis, and Test Details
The MT-ND1 gene is a gene found in the mitochondrial DNA (mtDNA) that encodes a subunit of complex I, which is a part of the electron transport chain in mitochondria. Mitochondrial complex I deficiency refers to a condition where there is a malfunction or reduced activity of complex I, leading to impaired energy production within cells.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of mitochondrial complex I deficiency, NGS genetic testing can be used to identify mutations or variations in the MT-ND1 gene and other relevant genes that may be responsible for the condition.
By analyzing the patient’s DNA, NGS genetic testing can provide valuable information about the specific genetic variants present in the MT-ND1 gene and other genes associated with mitochondrial complex I deficiency. This information can help in diagnosing the condition, predicting disease progression, and guiding treatment decisions.
It is important to note that NGS genetic testing for mitochondrial complex I deficiency is typically performed in specialized laboratories or genetic testing centers, and the results should be interpreted by a qualified healthcare professional or genetic counselor. The results of the test can provide valuable insights into the genetic basis of the condition and may inform personalized treatment plans or management strategies.
Test Components
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for MT-ND1 Gene Mitochondrial complex I deficiency NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with MT-ND1 Gene Mitochondrial complex I deficiency
| Test Name | MT-ND1 Gene Mitochondrial complex I deficiency Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MT-ND1 Gene Mitochondrial complex I deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MT-ND1 Gene Mitochondrial complex I deficiency |
| Test Details |
The MT-ND1 gene is a gene found in the mitochondrial DNA (mtDNA) that encodes a subunit of complex I, which is a part of the electron transport chain in mitochondria. Mitochondrial complex I deficiency refers to a condition where there is a malfunction or reduced activity of complex I, leading to impaired energy production within cells. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of mitochondrial complex I deficiency, NGS genetic testing can be used to identify mutations or variations in the MT-ND1 gene and other relevant genes that may be responsible for the condition. By analyzing the patient’s DNA, NGS genetic testing can provide valuable information about the specific genetic variants present in the MT-ND1 gene and other genes associated with mitochondrial complex I deficiency. This information can help in diagnosing the condition, predicting disease progression, and guiding treatment decisions. It is important to note that NGS genetic testing for mitochondrial complex I deficiency is typically performed in specialized laboratories or genetic testing centers, and the results should be interpreted by a qualified healthcare professional or genetic counselor. The results of the test can provide valuable insights into the genetic basis of the condition and may inform personalized treatment plans or management strategies. |
